Doyle Anthony 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 21, 2022
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-19+34,000→ 197,966 total - Award
Emp. Stock Option (Right to Buy)
2022-12-19+158,500→ 158,500 totalExercise: $10.63From: 2023-12-19Exp: 2032-12-19→ Common Stock (158,500 underlying)
Footnotes (2)
- [F1]Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.